REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
USD 5.54 Billion in 2029 | 16.8% | North America |
By Product Type | By Application | By End Use |
---|---|---|
|
|
|
SCOPE OF THE REPORT
Glycomics and Glycobiology Market Overview
The global Glycomics and Glycobiology market is expected to grow at a 16.8% CAGR from 2022 to 2029, from USD 5.54 Billion in 2029.
Glycomics and Glycobiology Market is primarily being driven by technological investments as well as economic growth. For other businesses in the region, developing nations present strategic advantages. Growth is being aided by technological advancements brought on by numerous government R&D investments, as well as drug discovery by biotechnology and pharmaceutical companies. Additionally, participation in research studies involving glycomics and proteomics is rising, which is anticipated to fuel market expansion over the course of the forecasted period. The overall growth of Glycomics and Glycobiology is also anticipated to be fuelled by an increase in sales of pharmaceuticals used to treat a range of severe chronic diseases.
ATTRIBUTE | DETAILS |
Study period | 2020-2029 |
Base year | 2021 |
Estimated year | 2022 |
Forecasted year | 2022-2029 |
Historical period | 2018-2020 |
Unit | Value (USD Billion) |
Segmentation | By Product Type, By Application, By End Use, By Region. |
By Product Type |
|
By Application |
|
By End Use |
|
By Region
 |
|
Bacterial glycomics research has resulted in the creation of a new drug, glycoconjugate vaccines, and biologically active glycan. The inherent complexity of glycan, as well as its full structural analysis, is a difficult subject. Technological advancements in glycomics tools have enabled researchers to understand the importance of glycan in biology, and this trend is expected to continue over the forecast period.
Glycomics and Glycobiology Market Segment Analysis
The global Glycomics and Glycobiology market is divided into four product categories: kits, enzymes, instruments, and reagents. In 2021, the instruments segment accounted for a sizable revenue share. Glycans perform a variety of biological functions, and understanding these functions and how they relate to diseases has increased the demand for precise analytical instruments that enable sensitive glycan monitoring in biological systems. These tools are required to understand the functions and properties of glycan in biological systems.
Some of the separation and mass spectrometric techniques used by this equipment include capillary electrophoresis, liquid chromatography in various modes, Matrix-Assisted Laser Desorption Ionisation Mass Spectrometry (MALDI-MS), and Electrospray Ionisation Mass Spectrometry (ESI-MS). As of the wide variety of glycan structures, it is currently thought that reliable glycomic research necessitates the integration of separation techniques and mass spectrometry.
The kit segment had the largest revenue share in 2021. The glycomics kits and arrays are used in a variety of medical applications, including cancer detection, disease diagnostics, and personalised therapy. Glycan arrays remain the primary tool for determining the glycan-binding specificity of proteins. Glycan-array data are now available for evaluation, incorporation, and application, and their volume and diversity are expanding. All of these changes have increased the amount of glycan-array data available for research.
Major companies are releasing numerous new glycomics-based glycan screening and labelling kits and assays in the market as a result of the rising demand for research and development activities, which is fuelling the segment’s revenue growth. This novel service represents the first glycan screening service tailored to the needs of customers in the CLD and Upstream development departments. By analysing hundreds of supernatant samples in less than two weeks, it enables our customers to quickly gather information on product quality.
The global Glycomics and Glycobiology market is classified into diagnostics, drug discovery & development, and other applications. In 2021, the drug discovery and development segment accounted for a sizable revenue share. Glycans play an important role in many biological processes that regulate individual differences in susceptibility to prevalent complex diseases and drug response. These glycosyl biomarkers show that glycans are potential targets for the development of personalised medicine, adding critical information to disease diagnosis and drug development.
In 2021, the diagnostics segment generated the most revenue. As a result of recent advances in analytical technology, glycomics and glycoproteomics are gaining traction in biomarker research. Glycomics research aids in patient diagnosis by identifying important treatment biomarkers. The glycomic analysis allows for a quick global comparison of glycomes within target tissues or bodily fluids, allowing for the discovery and use of novel biomarkers for cancer detection, diagnosis, and management.
The majority of disease biomarkers currently recognised by the Food and Drug Administration (FDA) are glycoproteins. Furthermore, crucial biological processes like immunity, growth, and brain development can all be significantly impacted by glycans. Abnormal glycosylation is present in many human diseases, including rheumatoid arthritis, cancer, and liver disease. The potential to use glycans as more precise diagnostic biomarkers is intriguingly presented by this. An index that is correlated with the presence of liver disease is provided by plasma ratios of four total protein-released N-glycan biomarkers. These are the main elements influencing the segment’s expansion.
The pharmaceutical and biotechnology industries, Contract Research Organisations (CROs), academic research institutions, and others make up the various end-use segments of the global Glycomics and Glycobiology market. In 2021, the segment of academic research institutions contributed significantly to revenue. Addressing health problems like cancer, infectious diseases, Alzheimer’s disease, and other neurological diseases may require innovation and new knowledge in the field of glycomics.
Researchers working on the basis of glycomics collaborate with partners from business, foundations, and research consortiums to create novel disease therapeutics, diagnostic tools, vaccines, and biomanufacturing processes. The development of this industry is being fueled by the fact that glycomics is drawing numerous projects and Research and Development (R&D) activities in this area. Government funding for glycomics research has increased, and significant businesses have also made investments. For instance, the network’s GlycoNet Integrated Services division saw an increase in funding of about USD 11 million to support researchers with resources like infrastructure and expertise. These are the main elements propelling the segment’s expansion.
Glycomics and Glycobiology Market Players
Key players involved in Water Corporation, Aligent Technologies, Bruker Corporation, Merck KGaA, New England Biolabs, Danaher Corporation, Shimadzu Corporation, Thermo Fischer Scientific, Takara Bio, Inc. and ProZyme Inc. Mergers and acquisitions, joint ventures, capacity expansions, significant distribution, and branding decisions by established industry players to boost market share and regional presence. They are also engaged in continuous R&D activities to develop new Product Products and are focused on expanding the Product Product Type portfolio. This is expected to increase competition and pose a threat to new market entrants.
Recent Developments:
27 JUN 2023: Water Corporation moves to open Wilson Inlet sandbar.
10 JULY 2023: Bruker Corporation, Professors Lucia Banci and Jack Freed Awarded the Prestigious Richard R. Ernst Prize in Magnetic Resonance
Who Should Buy? Or Key stakeholders
- Research and development
- Hospitals & Specialty Cardiac Centers
- Clinics & Physiotherapy Centers
- Office-Based Labs
- Government
- Healthcare
- Hospitals & Ambulatory Surgery Centers
Glycomics and Glycobiology Market Regional Analysis
Geographically, the Glycomics and Glycobiology market is segmented into North America, South America, Europe, APAC and MEA.
- North America: includes the US, Canada, Mexico
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
A sizable portion of revenue in 2021 came from Europe. The market in this region is experiencing revenue growth as a result of rising activities by key market players, as well as rising R&D activities and projects being conducted in relation to glycoscience research. For instance, in the EU project GlycoBioM – “Tools for the Detection of Novel Glycobiomarkers,” high-throughput screening methods have been used to discover new glycan biomarkers for a range of disorders. Research in glycoscience is promoted in Europe by national funding organisations like the Deustch Forschungsgemeinschaft in Germany and organisations like the European Commission. One project currently supported by the EC is the Euroglycosciences Forum, which is funded by the European Science Foundation Research Network Program. This forum promotes get-togethers and workshops that link members of the glycoscience community and aims to make glycoscience tools available to everyone.
North America captured the largest share of the Glycomics and Glycobiology market, owing to the presence of prominent market players in the US and increased investments by companies in glycobiology research activities. Additionally, it is anticipated to have the highest CAGR throughout the forecast period. The market is expanding in North America as a result of rising funding for glycobiology research, the presence of pharmaceutical and biotechnology firms, and improved healthcare infrastructure.
Key Market Segments: Glycomics and Glycobiology Market
Glycomics And Glycobiology Market By Product Type, 2020-2029, (USD Billion)
- Kits
- Instruments
- Reagents
- Enzymes
Glycomics And Glycobiology Market By Application, 2020-2029, (USD Billion)
- Drug Discovery And Development
- Immunology
- Oncology
- Diagnostics
- Other Application
Glycomics And Glycobiology Market By End Use, 2020-2029, (USD Billion)
- Pharmaceuticals And Biotechnological Companies
- Contract Research Organization
- Academic Research Institutes
Glycomics And Glycobiology Market By Regions, 2020-2029, (USD Billion)
- North America
- Europe
- Asia Pacific
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new End Use
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the Glycomics and Glycobiology market over the next 7 years?
- Who are the major players in the Glycomics and Glycobiology market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
- How is the economic environment affecting the Glycomics and Glycobiology market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the Glycomics and Glycobiology market?
- What is the current and forecasted size and growth rate of the global Glycomics and Glycobiology market?
- What are the key drivers of growth in the Glycomics and Glycobiology market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the Glycomics and Glycobiology market?
- What are the technological advancements and innovations in the Glycomics and Glycobiology market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the Glycomics and Glycobiology market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the Glycomics and Glycobiology market?
- What are the service offerings and specifications of leading players in the market?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON GLYCOMICS AND GLYCOBIOLOGY MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET OUTLOOK
- GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE, 2020-2029, (USD BILLION)
- KITS
- INSTRUMENTS
- REAGENTS
- ENZYMES
- GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION, 2020-2029, (USD BILLION)
- DRUG DISCOVERY AND DEVELOPMENT
- IMMUNOLOGY
- ONCOLOGY
- DIAGNOSTICS
- OTHER APPLICATION
- GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE, 2020-2029, (USD BILLION)
- PHARMACEUTICALS AND BIOTECHNOLOGICAL COMPANIES
- CONTRACT RESEARCH ORGANIZATION
- ACADEMIC RESEARCH INSTITUTES
- GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY REGION, 2020-2029, (USD BILLION)
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
9. COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- WATER CORPORATION
- ALIGENT TECHNOLOGIES
- BRUKER CORPORATION
- MERCK KGAA
- NEW ENGLAND BIOLABS
- DANAHER CORPORATION
- SHIMADZU CORPORATION
- THERMO FISCHER SCIENTIFIC
- PROZYME INC.
- TAKARA BIO, INC.*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY REGION (USD BILLION) 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â US GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â US GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â COLUMBIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â COLUMBIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â COLUMBIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC GLYCOMICS AND GLYCOBIOLOGY MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE GLYCOMICS AND GLYCOBIOLOGY MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â UK GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â UK GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â UK GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST & AFRICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST & AFRICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST & AFRICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST & AFRICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â Â Â Â Â UAE GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION) 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST & AFRICA GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE, USD BILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION, USD BILLION, 2020-2029
FIGURE10Â Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE, USD BILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY REGION, USD BILLION, 2020-2022
FIGURE 12          PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY PRODUCT TYPE (USD BILLION), 2021
FIGURE 14Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY APPLICATION (USD BILLION), 2021
FIGURE 15Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY END USE (USD BILLION), 2021
FIGURE 16Â Â Â Â Â Â Â Â Â Â GLOBAL GLYCOMICS AND GLYCOBIOLOGY MARKET BY REGION (USD BILLION), 2021
FIGURE 17Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 18Â Â Â Â Â Â Â Â Â Â WATER CORPORATION: COMPANY SNAPSHOT
FIGURE 19Â Â Â Â Â Â Â Â Â Â ALIGENT TECHNOLOGIES: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â BRUKER CORPORATION: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â MERCK KGAA: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â NEW ENGLAND BIOLABS: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â SHIMADZU CORPORATION: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â THERMO FISCHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â PROZYME INC: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â TAKARA BIO, INC.: COMPANY SNAPSHOT
FAQ
The Glycomics and Glycobiology market reached USD 1.37 billion in 2020 and is expected to grow at a CAGR of more than 16.8% through 2029, owing to the increasing in awareness about health.
The upcoming trend in the Glycomics and Glycobiology market is an opportunity for market growth.
The global Glycomics and Glycobiology market registered a CAGR of 16.8% from 2022 to 2029.
The North America Glycomics and Glycobiology market had largest market share of 43% in 2021. The increasing research and development activities and government funding programs, along with the growing burden of chronic diseases in the United States, are expected to create more opportunities for the North America region.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.